Search
-
Appendiceal Cancer
Our appendiceal cancer doctors, surgeons and other experts provide highly individualized care and personal attention at every step of the way during your diagnosis and treatment.
… If you have appendix cancer, the doctor, surgeons and other appendix cancer experts at Memorial Sloan Kettering will provide highly individualized care and personal attention at every step of the way during your diagnosis and treatment. Our experts see about 150 patients with various types of appendix
-
There are many types of stomach cancer. Most people with stomach cancer have a type called adenocarcinoma.
… What are the types of stomach cancer? Most people with stomach cancer have a type called adenocarcinoma (A-deh-noh-KAR-sih-NOH-muh). As many as 9 out of every 10 people with stomach cancer have adenocarcinoma. Adenocarcinoma is a kind of cancer that starts in the glandular tissue that lines organs. This
-
Familiarize yourself with the risk factors for endometrial (uterine) cancer, such as genetic factors and obesity, and ways to help prevent the disease.
… Before menopause, a woman’s ovaries normally produce two main types of hormones: estrogen and progesterone . Estrogen encourages the growth of endometrial cells in the uterus, whereas progesterone inhibits it. When a woman has high circulating levels of estrogen and low levels of progesterone over long
-
The PSA test measures the level of a protein made by prostate cancer cells in your blood. Learn how it is used to help diagnose prostate cancer.
… NBC’s Al Roker Shares Important Message About Prostate Cancer Screening Al Roker, anchor of NBC’s TODAY, shared an update on his successful treatment for prostate cancer at MSK in a recent segment on the broadcast. Learn more The prostate-specific antigen (PSA) test measures the level of a protein made
-
La prueba de PSA mide el nivel de una proteína producida por las células del cáncer de próstata en la sangre. Obtenga información sobre cómo se usa para diagnosticar el cáncer de próstata.
… NBC’s Al Roker Shares Important Message About Prostate Cancer Screening Al Roker, anchor of NBC’s TODAY, shared an update on his successful treatment for prostate cancer at MSK in a recent segment on the broadcast. Learn more La prueba de antígeno prostático específico (PSA) mide el nivel de una proteína
-
At Memorial Sloan Kettering, we're dedicated to helping you get back to living your life after treatment for cervical cancer.
… VIDEO | 01:52 Learn About MSK's Adult Survivorship Program Dr. Ginger Gardner highlights the expert care people receive after they finish active cancer treatment and move into MSK's Adult Survivorship Program. Video Details At Memorial Sloan Kettering, we know that even after you’ve finished your cancer
-
Explore the many ways that MSK can help you physically, emotionally, spiritually, and otherwise once treatment for gallbladder cancer ends.
… At Memorial Sloan Kettering, we know that even after you’ve finished gallbladder cancer treatments, you may still need our help. We’re committed to supporting you in every way we can — physically, emotionally, spiritually, and otherwise — for as long as you need us. We’ve built a program designed for
-
After diagnosing MDS, MSK doctors will determine which subtype you have. Learn more.
… There are many subtypes of MDS. The subtype is determined using the results of blood and bone marrow tests. (Learn about these tests and how MDS is diagnosed.) MDS subtype is determined using either the World Health Organization (WHO) classification system or the French-American-British (FAB) classification
-
Kidney Cancer (Renal Cell Cancer)
Clinical trials evaluate the safety and effectiveness of new ways to diagnose and treat kidney cancer. Your treatment team can help you decide if a trial is right for you.
… Clinical trials are research studies that test new ways to treat your cancer. They test new treatments, procedures, or devices to see how well they work and whether they might be even more effective than the many standard strategies we already have established to treat kidney cancers. Clinical trials